Endurazymes licenses a fluorescent test for hardier industrial enzymes

Endurazymes announced an exclusive license from Los Alamos National Laboratory on October 1 for technology intended to help enzyme developers discard weak candidates earlier.

The company, formally EnduraFAST Inc., plans to use the technology in its first commercial screening platform. Its target is a recurring industrial-biology problem: an enzyme that looks promising in one set of laboratory conditions may become unstable when exposed to the heat or chemical stress of a manufacturing process.

The measurement relies on a fluorescent reporter protein called hsFAST. According to the company’s technical description, the reporter can be joined to a protein of interest. A retained light signal can indicate that the combined system remains properly folded; a reduced signal can point to instability, misfolding or aggregation.

The reporter does not require oxygen for maturation, making the approach relevant to conditions where an oxygen-dependent fluorescent system would be less useful.

Stability is one screening question

A protein’s ability to retain its structure and an enzyme’s ability to perform a desired reaction are related questions, but they are not interchangeable. A bright signal does not establish that a candidate will produce enough of the intended product at an acceptable cost.

Endurazymes presents its method as an earlier decision step. Developers could use the stability signal to identify candidates worth advancing, then conduct more detailed activity tests on that smaller group.

The proposed service would give other manufacturers access to a federal laboratory’s measurement tool. The license establishes that commercial relationship, while the two-stage workflow preserves a necessary distinction: the fluorescent signal screens for structural stability; subsequent tests must establish useful enzyme activity.